Practice
Featured experience
Quanta Computer strategic collaboration with and investment in Rigetti
We are advising Quanta on the transaction
Avianca senior secured notes offering and exchange offer and consent solicitation
The transactions included a $1 billion senior secured notes offering and a $1.1 billion exchange offer and consent solicitation
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Spirit Airlines prearranged chapter 11 filing
We are advising Spirit Airlines in connection with entry into an RSA and negotiation of a prearranged chapter 11 plan
BRP Group acquisition of Burnham Benefits Insurance Services
Davis Polk advised BRP Group, Inc. on the entry into an agreement by its indirect subsidiary, Baldwin Krystyn Sherman…
Seer $336 million IPO and concurrent private placement
Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 10,592…
CSX acquisition of Pan Am Railways in New England
Davis Polk is advising CSX Corp. on its acquisition of New England’s Pan Am Railways, Inc., whose rail carrier subsidiaries…
Sycamore Partners acquisition of certain brands from Ascena Retail Group
We are advising Sycamore Partners on its acquisition
Bertelsmann $2.175 billion acquisition of Simon & Schuster
Davis Polk is advising Bertelsmann on the $2.175 billion acquisition by its global trade book publishing group, Penguin…
Maravai LifeSciences Holdings $1.863 billion IPO
Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of 69…
Olema Pharmaceuticals $240 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $240 million initial public…
Signify Health acquisition of PatientBlox
Davis Polk advised Signify Health on its acquisition of PatientBlox. The acquisition accelerates Signify’s prospective…
VF $2.1 billion acquisition of Supreme Holdings
We are advising VF on its acquisition
Novo Nordisk acquisition of Emisphere Technologies
Davis Polk is advising Novo Nordisk A/S on its $1.8 billion acquisition of Emisphere Technologies Inc. and related Eligen…